Organ Damage, BMI Linked to Fatigue in SLE
Cross-sectional study suggests fatigue is associated with damage accrual and body mass, not disease activity
-
By
-
Andrea Surnit
-
April 20, 2026
-
Clinical Scorecard: Organ Damage, BMI Linked to Fatigue in SLE
At a Glance
| Category | Detail |
|---|
| Condition | Systemic Lupus Erythematosus (SLE) |
| Key Mechanisms | Greater organ damage accrual and higher body mass index associated with fatigue. |
| Target Population | Patients with systemic lupus erythematosus, particularly those with clinically significant fatigue. |
| Care Setting | Tertiary care center outpatient visits. |
Key Highlights
- 52% of patients exhibited clinically significant fatigue.
- Higher organ damage scores (mean SLICC/ACR DI: 1.9 vs 1.1) in fatigued patients.
- Fatigue not correlated with disease activity (mean SELENA-SLEDAI score: 3).
- Racial differences observed in fatigue reporting, with non-Hispanic Whites more likely to report fatigue.
- Independent associations found between fatigue and pulmonary fibrosis, neuropathy, and high BMI.
Guideline-Based Recommendations
Diagnosis
- Assess fatigue using the Fatigue Severity Scale (FSS) with scores of four or higher indicating clinically significant fatigue.
Management
- Focus on managing organ damage and comorbid conditions, particularly pulmonary fibrosis and neuropathy.
Monitoring & Follow-up
- Monitor body mass index and organ damage accrual in patients with SLE.
Risks
- Increased risk of clinically significant fatigue associated with higher BMI and organ damage.
Patient & Prescribing Data
183 patients with systemic lupus erythematosus.
No significant association found between fatigue and use of prednisone or hydroxychloroquine.
Clinical Best Practices
- Evaluate fatigue in SLE patients regularly using standardized scales.
- Consider the impact of comorbidities on fatigue levels.
- Encourage weight management as part of comprehensive care for SLE patients.
References
